Bay Space biotech Guardant Well being introduced the industrial launch of its early-detection colon most cancers check on Monday, marking the newest twist in an escalating race to identify most cancers sooner and extra precisely.
The corporate’s check, often known as Protect, is obtainable to adults 45 and older who aren’t updated with present screening pointers, don’t have signs, and are at common danger of colon most cancers. Protect is a lab-developed check, that means that it hasn’t been permitted by the Meals and Drug Administration and that every pattern (a couple of tablespoon of blood) should be despatched to Guardant’s lab.
